TNFSF13 and lupus nephritis: Previous trials using atacicept (an inhibitor of both BAFF and APRIL) in the treatment of lupus nephritis patients effectively suppressed all fractions of B cells including LLPC but resulted in severe hypogammaglobulinemia and severe infections [38].